Drug
Zoldonrasib
Zoldonrasib: highest development phase Phase 3, developed by Revolution Medicines. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Revolution Medicines
Trials
| Drug | Phase | Indication |
|---|---|---|
| Zoldonrasib NCT07621718 | Phase 3 | Pancreatic Cancer |
| zoldonrasib NCT07777822 | Phase 3 | NSCLC |
Latest
No recent events.
Follow Zoldonrasib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.